using semaglutide FDA Warns Against Compounded For Type 2 Diabetes, Weight Loss What to Expect During Your

Until it goes through proper trials and regulatory approval, the risk-benefit math is difficult to evaluate

Specific variants in the GLP1R gene (such as rs6923761) can reduce the activity of GLP-1 receptors on your cells, meaning you may need a higher dose, a longer treatment period, or a different compound entirely to achieve results

However, when combined with GLP1RA, GIP enhances GLP1R activity, which may explain superior weight loss compared to GLP1RA alone

1 The safety and efficacy of compounded, oral, and microdosed meds, including treatments that have not been inspected and approved by the FDA, cannot be guaranteed